Position in VERU
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$485,387
+$77,373 QoQ
Shares Held
155,076
-16.0% QoQ
Ownership
0.910%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. VERU ranks #359 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in VERU
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $485,387 | 155,076 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $408,014 | 184,622 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $332,485 | 155,367 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $605,541 | 159,353 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $931,673 | 1,606,335 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,486,222 | 3,033,107 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,948,537 | 2,997,751 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,263,907 | 2,940,140 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,359,072 | 2,808,420 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $795,794 | 1,136,849 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $476,820 | 662,250 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $432,077 | 600,107 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $646,588 | 543,352 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,337,329 | 1,152,870 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,829,827 | 1,104,134 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,405,312 | 1,076,850 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,675,605 | 1,121,735 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,481,112 | 1,134,806 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,380,778 | 1,083,324 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,120,105 | 1,069,180 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,449,298 | 1,047,001 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,091,869 | 936,166 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,671,035 | 771,218 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,886,242 | 719,940 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,381,429 | 713,003 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,267,353 | 387,570 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||